Home
Products
• Product Development Focus
• Our Supergenerics Pipeline
• Lead Compound
• Target Identification
• Outlicensing
• Patents
• Alliances/Agreements
Investor Relations
• News Release
• Annual Reports
• Stock Quote
• Corporate Governance
|
Welcome to the official website of Advanomics Corporation | Advanomics Corporation is a leading-edge biopharmaceutical company focused on the research, development and commercialization of drugs and technologies for the treatment of various forms of cancer | Always check our website for new updates...
|
|
About Advanomics
• Corporate Overview
• Corporate History
• Business Focus
• Some Cancer Statistics
• Management
• Careers
• Contact us
• Directors
• Auditors
• Legal counsels
Target Identification
Copyright © 2007 Advanomics Corporation
In Addition to our Supergenerics pipeline, we have developed a new technology that allows us to directly identify all of the RNA’s that can be made from any given piece of DNA. By doing so, we are able to generate complete RNA profiles. This technology has been covered by a US Patent # 2005015877 filed December 24, 2003. With this technology, we are able to rapidly identify new anti-cancer targets by comparing the RNA profiles generated from normal tissue versus those generated from cancer tissue.